The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival benefit with regorafenib and/or trifluridine/tipiracil sequencing to rechallenge with anti-EGFR-based third-line regimens in metastatic colorectal cancer: A multicenter retrospective real-world subgroups comparison.
 
Carlo Signorelli
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - Bayer
 
Mario Giovanni Chilelli
No Relationships to Disclose
 
Michele Basso
No Relationships to Disclose
 
Maria Alessandra Calegari
Honoraria - Amgen; Merck; Pierre Fabre; SERVIER
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Merck; Pierre Fabre; SERVIER
 
Annunziato Anghelone
No Relationships to Disclose
 
Jessica Lucchetti
Employment - Fondazione Pol.Universitario Campus Biomedico
 
Alessandro Minelli
No Relationships to Disclose
 
Lorenzo Angotti
No Relationships to Disclose
 
Ina Valeria Zurlo
No Relationships to Disclose
 
Marta Schirripa
No Relationships to Disclose
 
Cristina Morelli
No Relationships to Disclose
 
Emanuela Dell'Aquila
No Relationships to Disclose
 
Donatello Gemma
No Relationships to Disclose
 
Domenico Cristiano Corsi
Speakers' Bureau - LEO Pharma
Travel, Accommodations, Expenses - Gilead Sciences; Pfizer; Pfizer; Pierre Fabre
 
Giulia Arrivi
No Relationships to Disclose
 
Federica Zoratto
No Relationships to Disclose
 
Maria Grazia Morandi
No Relationships to Disclose
 
Fiorenza Santamaria
No Relationships to Disclose
 
Rosa Saltarelli
No Relationships to Disclose
 
Enzo Maria Ruggeri
No Relationships to Disclose